Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Efficacy and Safety in Inadequately Treated Painful Diabetic Peripheral Neuropathy
NCT01057693Phase 3Completed
- Sponsor
- Viatris
- Start
- Mar 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of pregabalin in diabetic peripheral neuropathy (DPN), sponsored by Viatris. Started Mar 2010; status: completed.
02
Drugs
pregabalin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01057693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01057693.